Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-21-007672
Filing Date
2021-01-26
Accepted
2021-01-26 16:33:33
Documents
48

Document Format Files

Seq Description Document Type Size
1 F-1 tm2039250-2_f1.htm F-1 6120769
2 EXHIBIT 1.1 tm2039250d3_ex1-1.htm EX-1.1 287831
3 EXHIBIT 2.1 tm2039250d3_ex2-1.htm EX-2.1 268252
4 EXHIBIT 3.1 tm2039250d3_ex3-1.htm EX-3.1 19220
5 EXHIBIT 5.1 tm2039250d3_ex5-1.htm EX-5.1 23071
6 EXHIBIT 10.6 tm2039250d3_ex10-6.htm EX-10.6 69926
7 EXHIBIT 10.13 tm2039250d3_ex10-13.htm EX-10.13 13653
8 EXHIBIT 10.14 tm2039250d3_ex10-14.htm EX-10.14 122560
9 EXHIBIT 23.1 tm2039250d3_ex23-1.htm EX-23.1 2257
10 EXHIBIT 23.2 tm2039250d3_ex23-2.htm EX-23.2 4482
11 GRAPHIC lg_calliditas.jpg GRAPHIC 22912
12 GRAPHIC tm2039250d2-bc_egfr4clr.jpg GRAPHIC 49543
13 GRAPHIC tm2039250d2-bc_interem4clr.jpg GRAPHIC 46819
14 GRAPHIC tm2039250d2-bc_sumary4clr.jpg GRAPHIC 69012
15 GRAPHIC tm2039250d2-fc_pipeline4c.jpg GRAPHIC 75264
16 GRAPHIC tm2039250d2-lc_nefecon4clr.jpg GRAPHIC 74601
17 GRAPHIC tm2039250d2-ph_iga4clr.jpg GRAPHIC 229543
18 GRAPHIC tm2039250d2-ph_nefecon24clr.jpg GRAPHIC 32672
19 GRAPHIC tm2039250d2-tbl_changebwlr.jpg GRAPHIC 94190
20 GRAPHIC tm2039250d3_ex2-1img01.jpg GRAPHIC 2984
21 GRAPHIC tm2039250d3_ex2-1img02.jpg GRAPHIC 6011
22 GRAPHIC tm2039250d3_ex2-1img03.jpg GRAPHIC 17555
23 GRAPHIC tm2039250d3_ex2-1img04.jpg GRAPHIC 4961
24 GRAPHIC tm2039250d3_ex2-1img05.jpg GRAPHIC 3755
25 GRAPHIC tm2039250d3_ex2-1img08.jpg GRAPHIC 5897
26 GRAPHIC tm2039250d3_ex2-1img09.jpg GRAPHIC 8035
27 GRAPHIC tm2039250d3_ex2-1img010.jpg GRAPHIC 14229
28 GRAPHIC tm2039250d3_ex2-1img011.jpg GRAPHIC 5959
29 GRAPHIC tm2039250d3_ex2-1img012.jpg GRAPHIC 11802
30 GRAPHIC tm2039250d3_ex2-1img013.jpg GRAPHIC 10078
31 GRAPHIC tm2039250d3_ex2-1img014.jpg GRAPHIC 21351
32 GRAPHIC tm2039250d3_ex2-1img015.jpg GRAPHIC 12689
33 GRAPHIC tm2039250d3_ex2-1img016.jpg GRAPHIC 8307
34 GRAPHIC tm2039250d3_ex2-1img017.jpg GRAPHIC 10100
35 GRAPHIC tm2039250d3_ex2-1img018.jpg GRAPHIC 3627
36 GRAPHIC tm2039250d3_ex2-1img019.jpg GRAPHIC 7597
37 GRAPHIC tm2039250d3_ex2-1img020.jpg GRAPHIC 5122
38 GRAPHIC tm2039250d3_ex2-1img021.jpg GRAPHIC 2221
39 GRAPHIC tm2039250d3_ex2-1img022.jpg GRAPHIC 2524
40 GRAPHIC tm2039250d3_ex2-1img023.jpg GRAPHIC 5964
41 GRAPHIC tm2039250d3_ex2-1img06.jpg GRAPHIC 3481
42 GRAPHIC tm2039250d3_ex2-1img07.jpg GRAPHIC 6533
43 GRAPHIC tm2039250d3_ex10-13img01.jpg GRAPHIC 203036
44 GRAPHIC tm2039250d3_ex10-13img02.jpg GRAPHIC 331113
45 GRAPHIC tm2039250d3_ex10-13img03.jpg GRAPHIC 197895
46 GRAPHIC tm2039250d3_ex10-13img04.jpg GRAPHIC 43306
47 GRAPHIC tm2039250d3_ex10-14img001.jpg GRAPHIC 3421
48 GRAPHIC tm2039250d3_ex10-14img002.jpg GRAPHIC 10679
  Complete submission text file 0001104659-21-007672.txt   9228286
Mailing Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Filer) CIK: 0001795579 (see all company filings)

EIN.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-252436 | Film No.: 21554510
SIC: 2834 Pharmaceutical Preparations